Skip to main content

Table 1 Patient characteristics among insured and uninsured patients

From: Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations

  Insured Medicaid Uninsured
  Pre-USPSTF (2010–2012) No. (% or IQR) Post-USPSTF (2014–2016) No. (% or IQR) Pre-USPSTF (2010–2012) No. (% or IQR) Post-USPSTF (2014–2016) No. (% or IQR) P-valuea Pre-USPSTF (2010–2012) No. (% or IQR) Post-USPSTF (2014–2016) No. (% or IQR) P-valuea
Sample size 124,577 (54.88) 102,420 (45.12) 7,351 (47.63) 8,084 (52.37)   2,552 (63.15) 1,489 (36.85)  
Median age 65 (59–71) 66 (60–72) 66 (59–73) 63 (58–70)   61 (56–64) 62 (57–67)  
PSA, ng/mL       < 0.001    0.048
 ≤ 10 83,975 (75.52) 62,920 (68.69) 3,285 (53.02) 3,441 (49.21)   1,250 (55.07) 651 (49.28)  
 10 < PSA ≤ 20 15,253 (13.72) 14,882 (16.25) 1,224 (19.75) 1,362 (19.48)   399 (17.58) 213 (16.12)  
 > 20 11,969 (10.76) 13,799 (15.06) 1,687 (27.23) 2,189 (31.31)   621 (27.36) 457 (34.60)  
 Total 111,197 (100.00) 91,601 (100.00) 6,196 (100.00) 6,992 (100.00)   2,270 (100.00) 1,321 (100.00)  
Biopsy Gleason Score       < 0.001    0.004
  ≤ 6 51,845 (45.40) 32,133 (34.23) 2,344 (37.41) 1,966 (28.60)   823 (36.45) 399 (31.10)  
 7 43,401 (38.00) 39,845 (42.45) 2,364 (37.73) 2,893 (42.09)   865 (38.31) 491 (38.27)  
 ≥ 8 18,959 (16.60) 21,884 (23.32) 1,557 (24.85) 2,015 (29.31)   570 (25.24) 393 (30.63)  
 Total 114,205 (100.00) 93,862 (100.00) 6,265 (100.00) 6,874 (100.00)   2,258 (100.00) 1,283 (100.00)  
Stage      0.002     < 0.001
 Localized 99,138 (81.27) 75,388 (75.31) 5,153 (73.61) 5,199 (66.87)   1,762 (71.95) 987 (69.02)  
 Regional 17,031 (13.96) 16,855 (16.84) 952 (13.60) 1,230 (15.82)   350 (14.29) 186 (13.01)  
 Distant 5,813 (4.77) 7,859 (7.85) 895 (12.79) 1,346 (17.31)   337 (13.76) 257 (17.97)  
 Total 121,982 (100.00) 100,102 (100.00) 7,000 (100.00) 7,775 (100.00)   2,449 (100.00) 1,430 (100.00)  
Treatment       < 0.001    0.524
 No local therapy 64,670 (51.91) 58,790 (57.40) 5,089 (69.23) 5,570 (68.90)   1,634 (64.03) 1,041 (69.91)  
 Prostatectomy and/or radiotherapy 59,907 (48.09) 43,630 (42.60) 2,262 (30.77) 2,514 (31.10)   918 (35.97) 448 (30.09)  
 Total 121,982 (100.00) 100,102 (100.00) 7,000 (100.00) 7,775 (100.00)   2,449 (100.00) 1,430 (100.00)  
Race       < 0.001    0.004
 White 87,783
(71.64)
70,744
(70.03)
2,570
(35.47)
3,115
(38.92)
  1,137
(45.15)
575
(39.36)
 
 Black 18,268
(14.91)
15,773
(15.61)
1,955
(26.98)
2,265
(28.30)
  766
(30.42)
543
(37.17)
 
 Hispanic 10,459
(8.54)
9,146
(9.05)
1,791
(24.72)
1,841
(23.00)
  492
(19.54)
263
(18.00)
 
 Asian/Pacific Islander 5,624
(4.59)
5,015
(4.96)
873
(12.05)
715
(8.93)
  119
(4.73)
78
(5.34)
 
 American Indian/Alaska Native 396
(0.32)
335
(0.33)
56
(0.77)
67
(0.84)
  4
(0.16)
2
(0.14)
 
 Total 122,530
(100.00)
101,013
(100.00)
7,245
(100.00)
8,003
(100.00)
  2,518
(100.00)
1,461
(100.00)
 
  1. aMultinomial logistic regression with generalized logit function with insured group as reference group